A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Clinical trial NCT07266402 · RECRUITING

Trial details

NCT number: NCT07266402
Sponsor: Celldex Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Inducible Urticaria Cold Urticaria Cold-Induced Urticaria Symptomatic Dermographism

Start date: 2026-01-15
Primary completion: 2028-06-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.